Chagas disease in the United States: a call for increased investment and collaborative research

Nelson Iván Agudelo Higuita1,2, Norman L Beatty3,4, Colin Forsyth5

  • 1Department of Medicine, Section of Infectious Diseases, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Insights

Chagas disease, caused by Trypanosoma cruzi, affects 300,000 in the U.S. Research and public health initiatives are crucial for developing diagnostics, treatments, and understanding genetic variations for better patient outcomes.

Area of Science:

  • Neglected tropical diseases
  • Parasitic infections
  • American trypanosomiasis

Background:

  • Chagas disease, caused by Trypanosoma cruzi, is a significant public health concern in the United States, affecting an estimated 300,000 individuals.
  • The disease often remains asymptomatic for years, progressing to severe complications like cardiomyopathy in 30-40% of cases.
  • While prevalent in Latin America, local vector transmission in the southern U.S. and diagnostic/treatment challenges highlight its overlooked status.

Purpose of the Study:

  • To emphasize the critical need for enhanced research and public health initiatives in the United States concerning Chagas disease.
  • To highlight the role of U.S. research institutions in advancing treatment and diagnostic biomarker development.
  • To underscore the importance of investigating Trypanosoma cruzi genetic variations between North and South America for improved strategies.

Main Methods:

  • This viewpoint discusses current challenges and proposes future research directions.
  • It emphasizes the need for a multi-faceted approach involving public health programs and institutional research.
  • Analysis of genetic variations in Trypanosoma cruzi is proposed as a key methodological area.

Main Results:

  • Chagas disease poses a significant, yet underestimated, health burden in the U.S. with substantial long-term complications.
  • Current diagnostic and treatment access is limited, with gaps in healthcare systems and understanding of disease pathogenesis.
  • Genetic diversity of Trypanosoma cruzi is a critical factor influencing disease presentation and treatment efficacy.

Conclusions:

  • Urgent implementation of national and local programs is required to bolster healthcare responses for Chagas disease.
  • Focused research by U.S. institutions is vital for developing novel treatments and reliable biomarkers.
  • Understanding Trypanosoma cruzi genetic variations is essential for refining diagnostic and therapeutic approaches in the U.S.

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
2.0K
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
859
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
100
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
79
Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
159
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide...
79